Sidharth (Sid) Rupani (@sidrup) profile picture

Supply Chain Design, Technology, and Data Analytics for Development

Cape Town, South Africa
Joined June 2009
I’m going to be grooving to “Organise” by Asaka this end-of-year. Thanks to the Investing in Innovation (i3) team for truly rocking it at their event in Lagos. What a great song! youtu.be/_u4_iWCvZ5c @marakatherine1 @kojere @SalientAdvisory @TheYomiKazeem @rowenaluk
Diego Comin & Marti Mestieri use a global dataset of technology diffusion to argue that the primary differences now are not across countries, but within countries ("intensity of use") and that explains income divergence. What can we do to accelerate "intensity of use"?
1
What share of all deliveries in the US will be made by aerial drone in: A. 2025? B. 2030? By number? By product value? Question mainly for @elidourado on what he means by drone delivery will become “normal”. Also cc: @KellerRinaudo @keenanwyrobek @ODefawe @Yadav_supplychn
1
China is administering >5x the daily number of doses India is. Look at the spectacular divergence in pace since mid-April-2021. Campaign size and scale is not unprecedented. We have a clear comparative example and we are slow in comparison. Let's get up to 10M doses/day!
A snapshot of the unprecedented size & scale of world’s largest vaccination drive currently underway in India 🇮🇳
1
3
Lower antibody levels do not mean “doesn’t work well”. Antibody levels still likely above thresholds conferring protection for most fully vaccinated individuals. The paper says so itself.
1
Replying to @srajagopalan
From the same medium piece from May 2020. Recommending purchase agreements with mfgs as a way for a vaccine task force to build legitimacy with a big “quick win”. And for govt to show it is forward-thinking.
1
Replying to @srajagopalan
More detail from my longer Medium piece, where I explicitly call for AMCs for India medium.com/@sidrup/india-sho…
1
Replying to @srajagopalan
I’m not a pundit, but here’s what I said in print in May 2020. hindustantimes.com/analysis/…
2
Replying to @DrSidMukherjee
There is a lot of detail on the current Oxygen planning approach in the Supreme Court order after the suo motu hearing on Friday, April 30 Including first 4 pages here. Please let me know if you'd like me to include the full section (14 pages total)
Add in that they ordered 16 cr (160M) doses for 3 months (92 days). That's 1.73M doses a day. They were currently doing a pace of ~2.5M doses/day (which was far from sufficient). Central govt. portion of that is now DOWN to 1.73M. How are we going to get up to 10M doses/day?
So after Indian media reported that govt hadn't placed orders for vaccine, GoI releases data that it placed orders for 11 cr Covishield and 5 cr Covaxin. On Apr 28. For vaccine expansion from May 1. Like ordering Bhel Puri. pib.gov.in/PressReleseDetail…
2
We need a centralized control room, tracking *every single* oxygen tanker in real-time, expediting and constant communications to clear any issues. This is very do-able. We are talking about <2000 tankers pan-India. The Supreme Court thinks so too! Let's do this TODAY.
1
On Oxygen allocation and transport in India. One critical point from the Supreme Court order after suo motu hearing on COVID-19 on Fri, Apr 30, 2021 It is currently the responsibility of each State to arrange transport to pick up O2 allocated by center. This is not working!
1
1
Even some countries to whom have donated doses have vaccinated higher shares of their population! See for example Bangladesh and Nepal.
1
Where are we on this chart? We have no sense of urgency right now because case numbers are low. But NOW is the time to act. Let's take advantage of having low case numbers and lots of (Covishield) doses available. Let's protect ourselves.
1
Replying to @tylercowen
Worth noting what existing guidance for all other vaccines says on longer than recommended timing between doses. (@EricTopol @Dereklowe @ATabarrok) Source 1: cdc.gov/vaccines/hcp/acip-re… Source 2: immunize.org/technically-spe…
2
5
2
26
Bonus! (Not a supply chain focused piece) My favorite COVID-19 vaccine piece this week is by @VirusesImmunity & @RMedzhitov. A wonderful primer on immunity and how it is likely to work for COVID-19 vaccines. nytimes.com/2020/07/31/opini… I especially love that they end with this!
1
Next, a very nice @WSJ piece by @elaineywchen. Takes a wider view. Highlights mfg. & freight constraints; work being done to address them. Only has room for 1 sentence on (distribution) campaigns. Would've been really great to expand that further! wsj.com/articles/drugmakers-…
1
They identify low air freight capacity (and higher than normal prices as a result) as a key bottleneck. However, in the piece they also quote an estimate that a single 777 freighter could carry a million vaccine doses. If this is true, then the capacity scarcity disappears.
1